Woodcock's return to CDER may improve drug approval climate

05/19/2008 | RPM Report (free registration), The

Some analysts say Janet Woodcock's return to head the Center for Drug Evaluation & Research is having a positive impact on the drug approval environment at the FDA, citing more green lights for tough product approvals in recent months. Woodcock says there haven't been any changes to approval standards, but says that she has been involved in some recent approval decisions, particularly those using risk evaluation and mitigation strategies.

View Full Article in:

RPM Report (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY